Natera, Inc.

Natera, Inc.

Natera, Inc.

Date Founded




Type of Company


Employees (Worldwide)



Medical Support Services
IT Consulting & Services

Company Description

Natera, Inc. engages in the discovery, development, and commercialization of genetic testing services. It offers Panorama Non-Invasive Prenatal Test, Horizon Carrier Screening, Spectrum Pre-implantation Genetic Screening and Spectrum Pre-implantation Genetic Diagnosis, Anora Products of Conception and Non-Invasive Paternity Testing. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in San Carlos, CA.

Contact Data
Trying to get in touch with decision makers at Natera, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees


Chief Technology Officer & Co-Founder

President, Chief Executive Officer & Director

Chief Financial & Accounting Officer

Chief Operating Officer

Secretary & General Counsel

Chief Scientific Officer, Oncology

General Manager-Women's Health

Senior Vice President, Product & Strategy

Senior Vice President-Research & Development

Board of Directors

Co-Founder at Natera, Inc.

Partner at Sequoia Capital

Chief Medical Officer at Merck & Co., Inc.

President at Sofinnova Ventures, Inc.

Former Director at Natera, Inc.

Director-Global Healthcare Management at Massachusetts College of Pharmacy and Allied Health Sciences

Chief Technology Officer & Co-Founder at Natera, Inc.

Co-Founder & Managing Partner at Leerink Transformation Partners LLC

Former Partner at Decheng Capital LLC

President, Chief Executive Officer & Director at Natera, Inc.

Paths to Natera, Inc.
Potential Connections via
Relationship Science
Natera, Inc.
Owners & Shareholders
Details Hidden

Driehaus Capital Management LLC (the "Firm") is a privately-held, independent investment adviser based in Chicago, Illinois and also has an office in New York, New York. Driehaus has been a registered investment adviser with the U.S. Securities and Exchange Commission since March 11, 1983. With approximately $9.07 billion in assets under management, the Firm manages domestic, global, ex-U.S. and dedicated emerging markets equity investment strategies as well as long/short credit investment strategies. We have a global institutional investor base that includes corporate pensions, public funds, endowments, foundations, sub-advisory mandates, financial advisers and family offices. Our niche is that of a smaller, performance-oriented investment adviser with the resources of a much larger organization.

Details Hidden

Deerfield Management Co. focuses on investments in growth stocks across the healthcare sector. They target companies with sound fundamentals, long-term earnings growth potential and the potential to capitalize on market trends. Deerfield's approach is based on extensive fundamental research into healthcare sector assets and investment opportunities. They invest mainly in US companies or companies that issue securities available in US public markets. Although this is their focus, there is no geographic limitation on investments and Deerfield may invest outside the US when situations warrant. Their funds generally pursue one of 3 strategies: Large-Cap, Special Situations and Private Design.Deerfield's Large-Cap strategy invests mainly in debt and equity securities, including exchange traded derivative securities, of publicly-traded companies in the healthcare sector. The strategy seeks capital appreciation through a combination of security selection based on fundamental analysis, diversification through investments in stock, debt and derivatives and a mix of long and short positions.The firm's Special Situations strategy emphasizes investments in publicly traded healthcare companies with smaller market-caps. At least 90% of investments must in healthcare companies, and essentially all investments are healthcare related. Investments include equity, debt, royalties or other assets, some of which may have limited liquidity. The strategy makes both long and short investments and may utilize leverage.Deerfield's Private Design strategy invests in public and private healthcare companies using privately created instruments, structures and transactions. This may include, but is not limited to, joint ventures, project financing, contracting for revenue streams, purchasing products/services outright (including intellectual property), participating in LBOs, restructurings and outright buyouts, and developing/participating in the development and sale of therapeutics, medical devices and healthcare products/services.

Details Hidden

Rubric Capital Management's (RMC) Master Fund seeks to achieve capital appreciation and maximize risk-adjusted absolute returns. RCM employs a value-oriented long/short strategy comprised of, but not limited to, a book of deep-value long positions and an alpha short book that is core to the Master Fund's strategy. The Master Fund will generally seek to maintain a low net exposure in pursuing its objective, and thus RCM believes that the Master Fund's performance will likely depend to a greater degree on individual stock selection than it will on movements in broad market averages. The Master Fund employs a fundamental and multi-year perspective in identifying its core investments from a universe generally comprised of equities and debt in all sectors. RCM implements a disciplined approach to risk management and capital preservation at the position, portfolio and firm levels in seeking to maximize the delivery of alpha from both long and short investments.^

Recent Transactions
Details Hidden

Natera, Inc. issued Common Stock

Details Hidden

Natera, Inc. issued Common Stock

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Escrow Agent

Advised onNatera, Inc. issued Common Stock


Advised onNatera, Inc. issued Common Stock


Advised onNatera, Inc. issued Common Stock


Advised onNatera, Inc. issued Common Stock

Legal Advisor

Advised onNatera, Inc. issued Common Stock

Legal Advisor

Advised onNatera, Inc. issued Common Stock

Advisors & Consultants
Legal Advisor

Former Attorney at Davis Polk & Wardwell LLP


Professional at Sullivan & Associates


OPKO Health, Inc. engages in the provision of healthcare services. It operates through the Diagnostics and Pharmaceuticals segments. The Diagnostics segment comprises clinical laboratory operations which acquired through the Bio-Reference and point-of-care operations. The Pharmaceuticals segment includes the pharmaceutical operations acquired in Chile, Mexico, Ireland, Israel, and Spain; and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Yale-New Haven Health Services Corp. operates as a non-profit organization that provides healthcare services. It offers geriatrics, oncology, neurology and neurosurgery, orthopedics, primary care, transplantation, clinical programs and services, health education, and research and clinical trials. The company was founded in 1995 and is headquartered in New Haven, CT.

QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.

Key Stats and Financials As of 2018
Market Capitalization
Total Enterprise Value
Earnings Per Share
Net Profit
Total Debt
Total Equity
Enterprise Value Sales
TEVNet Income
Debt TEV
Three Year Compounded Annual Growth Rate Of Revenue
Five Year Compounded Annual Growth Rate Of Revenue
Details Hidden

Claremont Creek Partners (CCP) invests in early-stage information technology companies. The firm is particularly interested in the following areas: (1) mobility including voice, data and converging platforms that facilitate collaboration in non-hierarchical, widely distributed organizations (2) healthcare including research and clinical information technology applications such as instrumentation, patient management systems and bio-informatics (3) energy efficiency including capital efficient technologies that relate to energy efficiency retrofits, monitoring and controls and platforms that improve the delivery of energy-related services and (4) security including both the digital and physical systems that comprise mobile, small business and enterprise computing environment. CCP is also interested in investments in other developing areas including VoIP, alternative energy, payment processing and distributive workforce collaboration. The firm places special emphasis on opportunities located beyond Silicon Valley. They invest in early-stage companies that have typically already received angel funding but have not yet participated in a traditional first round of venture finance. Investments generally range from $500,000 to $3 million with the potential for follow-on investments.

Details Hidden

Harmony Partners is a bi-coastal boutique venture capital firm whose mission is to enable software entrepreneurs to optimize expansion stage financings. With offices in New York City and Silicon Valley, Harmony fills a gap in the market for entrepreneur-friendly expansion stage capital. Harmony eliminates the deal constraints of traditional growth equity firms: $30-50 million minimum check sizes, >20% ownership targets, mandatory board seats, vetoes on M&A events, and multi-layered decision making. As such, the firm works collaboratively with Founders to craft the ideal financing that minimizes dilution, saves the company time and effort, while accommodating insider appetite and making room for strategics if relevant. Harmony has a longer-term orientation than most funds because the majority of its capital comes from seven billionaire family offices, and as result, the firm looks to buy in the IPO, not sell. Since 1993, the founding partners have invested in over 80 technology-driven companies including Anaplan, AppDynamics, Aveksa, ComScore, Coremetrics, E*Trade, Intersect ENT, Natera, Predictive Systems, Postmates, Priceline, Peribit, Scopus, Spotify, SS&C, Xactly, and Zerto. To learn more, please visit

Illumina, Inc. Medical Support Services | SAN DIEGO, CA

Illumina, Inc. engages in the development and manufacture of integrated systems for the analysis of genetic variation and function. It operates through the Core Illumina and Consolidated Variable Interest Entity segments (VIE). The Core Illumina segments serve customers in the research, clinical and applied markets, and enable the adoption of genomic solutions. The Consolidated VIE segment includes activities of GRAIL and Helix. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Streck, Inc. Biotechnology | Omaha, NE

Streck, Inc. manufactures hematology, chemistry, and immunology products for the clinical laboratory. It offers technical and customer support services, pipet verification, and statistics. The company was founded by Wayne Ryan in 1971 and is headquartered in Omaha, NE.

Veeva Systems, Inc. Other Business & Consulting Services | PLEASANTON, CA

Veeva Systems, Inc. engages in the provision of industry-specific, cloud-based software solutions for the life sciences industry. Its solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. The firm's customer relationship management solutions enable its customers to increase the productivity and compliance of their sales and marketing functions. Its regulated content management and collaboration solutions enable its customers to more efficiently manage a regulated, content-centric processes across the enterprise. The company's customer master solution enables customers to more effectively manage complex healthcare provider and healthcare organization data. The company was founded by Mark Armenante, Peter P. Gassner, Doug Ostler, Mitch Wallace and Matthew J. Wallach on January 12, 2007 and is headquartered in Pleasanton, CA.

OPKO Health, Inc. Pharmaceuticals - MIAMI, FL

OPKO Health, Inc. engages in the provision of healthcare services. It operates through the Diagnostics and Pharmaceuticals segments. The Diagnostics segment comprises clinical laboratory operations which acquired through the Bio-Reference and point-of-care operations. The Pharmaceuticals segment includes the pharmaceutical operations acquired in Chile, Mexico, Ireland, Israel, and Spain; and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Laboratory Corporation of America Holdings Medical Support Services - Burlington, NC

LabCorp provides leading-edge medical laboratory tests and services through a national network of primary clinical laboratories and specialized Centers of Excellence. Recognized for our innovation, quality, and customer convenience, LabCorp delivers timely, accurate results for improved patient care. With scientific expertise in esoteric testing, genomics, and clinical and anatomic pathology, LabCorp performs more than 1 million tests on more than 370,000 specimens each day. LabCorp is a pioneer in applying advances in medicine and science to laboratory testing, with more than 35 years of experience in serving physicians and their patients. LabCorp operates a sophisticated laboratory network, with corporate headquarters in Burlington, NC, and more than 30,000 employees nationwide. Our 220,000 clients include physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies. Laboratory Corporation of America Holdings is listed on the New York Stock Exchange (NYSE) under ticker symbol LH

PerkinElmer, Inc. Industrial Machinery & Manufacturing - Waltham, Massachusetts

As a global technology leader, PerkinElmer is taking action to harness the power of insights and transform them into knowledge to deliver innovative, differentiated solutions for our customers. From critical therapeutic and disease research and prenatal screening, to environmental testing and industrial monitoring, we are actively engaged in improving health and advancing quality and longevity of life all around the world. From multi-vendor laboratory services, software and informatics, to clinical lab testing and unparalleled customer care, we have the people, tools and resources to help customers solve their business and scientific goals. Our core competencies, coupled with our commitment to excellence, provide a strong foundation for delivering optimal service and support. By encouraging exploration, ingenuity and integrity, together with teamwork and employee development, at PerkinElmer we live our mission, every day

Awards & Honors
World Economic Forum - Technology Pioneers
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Natera, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Natera, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Natera, Inc..
  • be_ixf; php_sdk; php_sdk_1.4.15